Product Briefs – SeptiCyte LAB

Immunexpress, Inc. published in the American Journal of Respiratory and Clinical Care Medicine the design and results of clinical trials validating SeptiCyte™ LAB in the discrimination of sepsis from non-infectious systemic inflammatory response syndrome (SIRS) in the Intensive Care Unit (ICU) of hospitals.

Read More

International Sepsis Forum 2016

International Sepsis Forum 2016 December 6-8, 2016 Paris, France. Marc Bonten, founder of the MARS sepsis consortium presented SeptiCyte™ LAB data and by Thierry Calandra, author of the international Surviving Sepsis campaign also discussed the utility of SeptiCyte™ in ICU management. Independent investigators from the Utrecht Medical Centre presented data from two investigator lead trials…

Read More

FDA public hearing: Microbiology Medical Devices Panel for Sepsis

FDA public hearing: Microbiology Medical Devices Panel for Sepsis November 10, 2016 Washington, DC. This was an open hearing on how recent regulatory changes affect the application of host response sepsis diagnostics for the clinical management of Antibiotics. Attended by the FDA Molecular Diagnostics Advisory Board IXP Staff in Attendance: Leo McHugh, Roy Davis

Read More